Cary Street Partners Investment Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
Cary Street Partners Investment Advisory's IBB Position: Q2 2026 in Review
Cary Street Partners Investment Advisory reduced its iShares Biotechnology ETF (IBB) stake by 6.8% in Q2 2026, selling an estimated $72.2K and leaving 5,794 shares worth $1.1M. The position accounts for 0.22% of the portfolio, ranked #104.
Cary Street Partners Investment Advisory first reported a position in IBB in Q3 2020 and has held it in 8 quarters since. 699 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Cary Street Partners Investment Advisory held 5,794 shares of iShares Biotechnology ETF worth $1.1M as of Q2 2026.
- Cary Street Partners Investment Advisory sold 420 iShares Biotechnology ETF shares in Q2 2026, an estimated $72.2K.
- iShares Biotechnology ETF made up 0.22% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #104 holding.
- Cary Street Partners Investment Advisory first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 8 quarters since.
- 699 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.